Quantcast

Latest asthma Stories

2014-09-08 12:29:32

For U.S. Media Only RIDGEFIELD, Conn., Sept. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented new data from the company's Phase III trial program (UniTinA-asthma(®)) evaluating tiotropium in asthma, including the first study assessing the efficacy and safety of tiotropium in adolescent patients with symptomatic asthma. These data were unveiled during an oral session at the European Respiratory Society (ERS) International Congress 2014 in Munich, Germany. Tiotropium is...

infant sleeping on fur
2014-09-08 04:00:44

Lauren Anderson, European Lung Foundation Sleeping on animal fur in the first three months of life might reduce the risk of asthma in later childhood a new study has found. The new research, presented at the European Respiratory Society (ERS) International Congress in Munich on September 8, 2014, suggests that exposure to the microbial environment in animal skin and fur could have a protective effect against asthma and allergies. Previous studies have suggested that exposure to a...

2014-09-04 23:10:57

Dr. Anne Marie Salapatek, CSO at Inflamax Research, will be presenting clinical trial data demonstrating the utility of Environmental Exposure Chambers in asthma and allergic rhinitis research at upcoming 2014 European Respiratory Society conference in Munich, Germany, September 6-10. Toronto, ON (PRWEB) September 04, 2014 Inflamax Research Inc., a full-service CRO, announced today that their Chief Science Officer, Dr. Anne Marie Salapatek, will be presenting clinical trial data...

2014-09-04 08:31:03

Company to scale FDA-cleared digital therapeutic to tackle $100 billion cost of treating asthma and chronic obstructive pulmonary disease (COPD) MADISON, Wisc. and WAYNE, Penn., Sept. 4, 2014 /PRNewswire/ -- Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced that it raised $14.5 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor The Social+Capital Partnership....

2014-09-02 08:29:36

MONROVIA, Calif., Sept. 2, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced the appointment of Debra Zack, M.D., Ph.D., vice president, clinical development and the appointment of Lloyd Rowland, senior vice president, chief compliance officer and general counsel. "Debra's expertise in biologics...

2014-09-02 04:21:24

QXFORD, England, September 2, 2014 /PRNewswire/ -- Triggers milestone payment from Mylan Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that its Marketing Authorisation Application (MAA) for PSX1001 has been validated and is being assessed under the Decentralised Procedure (DCP), in which the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is...

asthma mold
2014-08-31 05:25:06

Rayshell Clapper for redOrbit.com - Your Universe Online The allergen and fungi mold is gross. It looks gross in its variety of colors. It grows in typically gross places (around toilet bowls, under sinks, in nooks and crannies). It feels gross and slimy if one happens to accidentally touch it. And frankly, it can smell pretty gross. When we walk into a place that has a plethora of mold, our noses tell us right away. Yes, mold is gross. And it is dangerous. There are types of molds...

2014-08-21 12:25:49

Efficacy on Reducing Exacerbations and Hospitalizations is One of the Key Drug Attributes for Formulary Inclusion, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that the asthma market in Brazil and Mexico currently faces severe coverage restrictions. The uptake of several newly approved agents, the anticipated label extension of Boehringer Ingelheim/Pfizer's Spiriva for this indication and the launch of...

2014-08-20 16:25:21

LONDON, Aug. 20, 2014 /PRNewswire/ -- GlaxoSmithKline plc today announced that the FDA has approved Arnuity(TM) Ellipta(®) (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm. The approved doses are Arnuity Ellipta 100mcg and 200mcg. Arnuity Ellipta is administered once daily via the dry...

2014-08-19 16:29:04

VIENNA, Va., Aug. 19, 2014 /PRNewswire-USNewswire/ -- Children with asthma and food allergies are vulnerable to bullying at school and online, often by classmates who tease or harass them because they're "different." It may be an age-old problem, but it must be addressed if we expect kids to be able to focus on their studies. Stopping confrontations before they start creates an environment where all children feel protected. "The keys to preventing bullying are self-confidence and...


Latest asthma Reference Libraries

Journal of Allergy and Clinical Immunology
2012-05-14 11:51:18

The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related